NCT02125591

Brief Summary

The purpose of this study is to evaluate improvement in balance after receiving physical therapy when augmented by CN-NINM than when augmented by a placebo (sham CN-NINM).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2014

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 29, 2014

Completed
1.3 years until next milestone

Study Start

First participant enrolled

August 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

May 22, 2015

Status Verified

October 1, 2014

Enrollment Period

1.3 years

First QC Date

April 7, 2014

Last Update Submit

May 21, 2015

Conditions

Keywords

Mild Traumatic Brain Injury

Outcome Measures

Primary Outcomes (1)

  • Change in Sensory Organization Test (SOT)

    Comparison of the SOT score between the treatment group and sham group at the intermediate follow-up.

    12 weeks

Secondary Outcomes (7)

  • Change in post-concussive symptoms using Neurobehavioral Symptom Inventory (NSI)

    12 weeks

  • Change in dizziness and unsteadiness measured by Dizziness Handicap Inventory (DHI)

    12 weeks

  • Change in space and motion discomfort measured by Situational Characteristics Questionnaire (SitQ)

    12 weeks

  • Change in quality of life measured using Short Form 36 (SF-36)

    12 weeks

  • Change in symptoms of post-traumatic stress disorder (PTSD) measured using the unspecified PTSD checklist (PCL-C)

    12 weeks

  • +2 more secondary outcomes

Study Arms (2)

Active PoNS CN-NINM

EXPERIMENTAL

Active CN-NINM PoNS - Active cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy

Device: Active CN-NINM PoNS

Sham PoNS CN-NINM

SHAM COMPARATOR

Sham CN-NINM PoNS - Sham cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy

Device: Sham CN-NINM PoNS

Interventions

Delivery of active stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.

Also known as: Active cranial-nerve non-invasive neuromodulation (CN-NINM), Portable Neuromodulation Stimulator (PoNS)
Active PoNS CN-NINM

Delivery of sham stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.

Sham PoNS CN-NINM

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Veteran or Servicemember
  • to 50 years old
  • Sustained one or more mild traumatic brain injury (mTBI)s
  • Demonstration of balance deficits on the Sensory Organization Test (a composite score of 75 or less (1/3 sample) and 72 or less (2/3 sample))
  • Available for the duration of the study

You may not qualify if:

  • History of traumatic brain injury (TBI) of any severity other than mild TBI
  • Presence of active substance abuse condition
  • Any condition for which posturography is contraindicated (e.g. leg amputation or fracture)
  • Diagnosed neurological disorder with balance sequelae, other than TBI (e.g. Parkinson's disease, incomplete spinal cord injury, or Multiple Sclerosis)
  • Orthostatic hypotension as defined by:
  • A systolic blood pressure decrease (from supine to sitting) of at least 20 mmHg
  • A diastolic blood pressure decrease of at least 10 mmHg, or
  • A pulse increase of 30 beats or more per minute with associated signs or symptoms of cerebral hypoperfusion
  • An implanted medical device
  • Pregnancy
  • Oral infection
  • Known transmissible disease (HIV, hepatitis, influenza, TB)
  • Exam signs of serious disorder other than mTBI as defined by facial asymmetry, hoarseness and dysarthria (e.g. tumor, stroke).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

McGuire Veterans Affairs Medical Center

Richmond, Virginia, 23249, United States

Location

Virginia Commonwealth University

Richmond, Virginia, 23298-3038, United States

Location

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • David X Cifu, MD

    VA Department of Physical Medicine and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • William C Walker, MD

    Virginia Commonwealth University (VCU)

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2014

First Posted

April 29, 2014

Study Start

August 1, 2015

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

May 22, 2015

Record last verified: 2014-10

Locations